NCT06593132

Brief Summary

The center plans to carry out a prospective clinical study of single hole total endoscopic breast conserving surgery for early breast cancer compared with open breast conserving surgery, to provide high-level evidence-based medical evidence for the development of endoscopic breast conserving surgery for early breast cancer.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2023

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2023

Completed
1.7 years until next milestone

First Submitted

Initial submission to the registry

August 27, 2024

Completed
23 days until next milestone

First Posted

Study publicly available on registry

September 19, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2025

Completed
Last Updated

September 19, 2024

Status Verified

September 1, 2024

Enrollment Period

1.9 years

First QC Date

August 27, 2024

Last Update Submit

September 10, 2024

Conditions

Keywords

breast conserving surgerysingle port endoscopicearly breast cancer

Outcome Measures

Primary Outcomes (1)

  • Six months after operation SURVIVAL EFFECTS

    To compare the overall survival (OS) within 6 months after single-port endoscopic breast-conserving surgery and open breast-conserving surgery.

    From enrollment to the end of 6 months after surgery

Secondary Outcomes (3)

  • Intraoperative blood loss

    From the beginning to the end of the operation

  • Postoperative drainage volume in the first three days after breast conserving surgery

    3 days after surgery

  • Length of surgical incision

    1 week after surgery

Study Arms (2)

single port endoscopic breast conserving surgery

Endoscopic breast conserving surgery, which uses breast endoscope for breast conserving surgery, can not only preserve the breast completely, but also meet the appearance needs of patients with breast preservation, and has more advantages than traditional surgery.

Procedure: endoscopic breast conserving surgery

open breast conserving surgery

On the surface of the breast tumor centered, is apart from the 2 cm do arc, radial incision tumor, tags in the cut edge around the joints and removing tissue inspection, to ensure the cut edge negative.

Procedure: endoscopic breast conserving surgery

Interventions

Breast endoscopy technology completes complex surgical operations through small incisions, achieving aesthetically pleasing results while ensuring tumor safety.

open breast conserving surgerysingle port endoscopic breast conserving surgery

Eligibility Criteria

Age20 Years - 70 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsAll participants are women
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Female patients aged 20-70 years who are eligible for breast-conserving surgery and are willing to undergo breast-conserving surgery.

You may qualify if:

  • Breast cancer confirmed by pathology;
  • Tumor \<5 cm, TNM stage 0-II;
  • Single Port Endoscopic or traditional open surgery; (4)20 to 70 years old female patients.

You may not qualify if:

  • Bilateral breast cancer;
  • Reconstruction after breast conserving surgery ;
  • Basic information is not complete;
  • Breast conserving surgery was converted to modified radical resection or subcutaneous adenoidectomy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

the First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, 710061, China

RECRUITING

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Central Study Contacts

Zhaoli Nan, bacheior

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
6 Months
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
chief physician

Study Record Dates

First Submitted

August 27, 2024

First Posted

September 19, 2024

Study Start

January 1, 2023

Primary Completion

December 1, 2024

Study Completion

June 1, 2025

Last Updated

September 19, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations